Discover 1,725 paid clinical trials in Detroit, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,725
Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma
for
Low Grade Upper Tract Urothelial Carcinoma
Location: Royal Oak MI, Ann Arbor MI, Cleveland OH, Columbus OH,
Sponsor: Tyra Biosciences, Inc
Sex: All
Age: 18+
Code: NCT07265947
Phase 2, Recruiting
Virtue® SAB in the Treatment of Coronary ISR Trial
for
Coronary Artery Disease
Location: Royal Oak MI, Indianapolis IN, Cincinnati OH,
Sponsor: Orchestra BioMed, Inc
Sex: All
Age: 18+
Code: NCT07045194
Recruiting
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
for
Small Cell Lung Carcinoma,
Location: Royal Oak MI, Iowa City IA, Montreal, Boston MA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07006727
Phase 1, Recruiting
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)
for
Acute Decompensated Heart Failure
Location: Royal Oak MI, Ann Arbor MI, Cleveland OH,
Sponsor: Reprieve Cardiovascular, Inc
Sex: All
Age: 22+
Code: NCT06898515
Recruiting
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
for
Moderate Aortic Valve Stenosis
Location: Royal Oak MI, West Bloomfield MI, Cleveland OH,
Sponsor: Kardigan, Inc.
Sex: All
Age: 50+
Code: NCT07001800
Phase 2, Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Nectero EAST System Clinical Study
for
Abdominal Aortic Aneurysm
Location: Royal Oak MI, Cleveland OH, Columbus OH, Pittsburgh PA,
Sponsor: Nectero Medical, Inc.
Sex: All
Age: 21 - 70+
Code: NCT06001918
Phase 2, Phase 3, Recruiting
Sacral Neuromodulation for Chronic Pelvic Pain
for
Chronic Pelvic Pain Syndrome
Location: Royal Oak MI
Sponsor: Corewell Health East
Sex: Female
Age: 22 - 70
Code: NCT06150599
Recruiting
Evaluating the Role of the Guidewire in Peripheral Intravenous Access: A Randomized Controlled Trial of Ultrasound-Guided Catheter Survival
for
Peripheral Intravenous Vein Catheter Phlebitis,
Location: Royal Oak MI
Sponsor: Corewell Health East
Sex: All
Age: 18+
Code: NCT06107361
Recruiting
Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR
Location: Royal Oak MI, Cincinnati OH, Rochester MN, Quebec,
Sponsor: Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Sex: All
Age: 18+
Code: NCT05459233
Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for
Triple Negative Breast Cancer
Location: Royal Oak MI, Grand Rapids MI, Columbus OH,
Location: Royal Oak MI, Toledo OH, Grand Rapids MI, Columbus OH,
Sponsor: United Therapeutics
Sex: All
Age: 18+
Code: NCT05943535
Phase 3, Recruiting
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
Location: Royal Oak MI, Ypsilanti MI, Lansing MI, Saginaw MI,
Sponsor: University of British Columbia
Sex: All
Age: 0+
Code: NCT04634240
Recruiting
Smart Ankle-Foot Orthosis to Improve Stroke Outcomes: Smart AFO
for
Stroke
Location: Troy MI, Edmonds WA
Sponsor: Orthocare Innovations, LLC
Sex: All
Age: 18+
Code: NCT05619484
Phase 2, Recruiting
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
for
Non-small Cell Lung Cancer
Location: Royal Oak MI, Cincinnati OH, Edgewood KY, Rochester NY,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06561386
Phase 3, Recruiting
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
for
High-Risk Non-Muscle-Invasive Bladder Cancer
Location: Royal Oak MI, Troy MI, Cleveland OH, Columbus OH,